Showing results (91-100 of 179) with videos related to

Sort By:
Pageof 18
Annals of Surgical Oncology|May 13, 2025
Resectable Pancreatic Cancer with CA19-9 > 500 U/mL: A Biological Indicator for Survival Benefit with Intensive Neoadjuvant ChemotherapyKojiro Omiya, Atsushi Oba, Kota Sugiura, et al.
Clinical Journal of Gastroenterology|September 8, 2020
A case of percutaneous transhepatic portal vein stent placement and endoscopic injection sclerotherapy for duodenal variceal rupture occurring during chemotherapy for unresectable perihilar cholangiocarcinomaKoshiro Fukuda, Takashi Sasaki, Toshiaki Hirasawa, et al.
DEN Open|February 27, 2023
Removal of Duckbill-type laser-cut anti-reflux metal stents: Clinical evaluation and in vitro studyYuto Yamada, Takashi Sasaki, Tsuyoshi Takeda, et al.
Pancreas|December 4, 2025
Clinical Practice Guidelines for Pancreatic Cancer 2025 From the Japan Pancreas Society: A SynopsisToshiya Abe, Masafumi Nakamura, Chigusa Morizane, et al.
DEN Open|October 30, 2023
Ruptured cystic artery pseudoaneurysm after self-expandable metal stent placement for malignant biliary obstructionTakafumi Mie, Takashi Sasaki, Kiyoshi Matsueda, et al.
Current Oncology (Toronto, Ont.)|August 25, 2023
Safety and Effectiveness of Chemotherapy in Elderly Biliary Tract Cancer PatientsTakeshi Okamoto, Tsuyoshi Takeda, Takashi Sasaki, et al.
International Journal of Clinical Oncology|September 16, 2017
A retrospective analysis of ramucirumab monotherapy in previously treated Japanese patients with advanced or metastatic gastric adenocarcinomaSatoshi Murahashi, Daisuke Takahari, Takeru Wakatsuki, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|January 15, 2019
FOLFIRINOX for locally advanced pancreatic cancer: Results and prognostic factors of subset analysis from a nation-wide multicenter observational study in JapanIppei Matsumoto, Keiko Kamei, Katsuhiro Omae, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|June 21, 2025
Clinical predictors of KRAS mutation detection in liquid biopsies for pancreatic ductal adenocarcinomaTakaaki Furukawa, Ippei Fukada, Naomi Hayashi, et al.
Cancers|January 21, 2023
Treatment Outcomes and Prognostic Factors of Gemcitabine Plus Nab-Paclitaxel as Second-Line Chemotherapy after Modified FOLFIRINOX in Unresectable Pancreatic CancerTakafumi Mie, Takashi Sasaki, Tsuyoshi Takeda, et al.
Pageof 18